Pall Corporation (PLL) has announced the acquisition of MicroReactor Technologies Inc. (MRT), a privately held U.S. biotechnology company. MicroReactor has developed a reliable, easy-to-use and cost-effective miniature bioreactor technology platform.

The acquisition of MicroReactor, which has patented its approach to high throughput miniature bioreactor equipment and disposables, expands Pall’s Total Fluid ManagementSM capabilities in the $1 billion biopharmaceuticals process monitoring and process development market. Terms of the deal were not disclosed.

Speed to market continues to be a critical driver in the biopharmaceuticals industry. High Throughput Process Development is a rapidly emerging approach that enables biotech drug development activities to be accomplished much faster and with less material. As a starting point for new biotech drug development, cell culture optimization can greatly benefit from this approach.

Founded in 2003 in Mountain View, California, MicroReactor quickly gained market recognition for its miniature bioreactor platform. The platform is able to improve cell culture process development through a fast and accurate assessment of bioreactor performance.

The Zacks Consensus Estimate for the company stands at $2.02 for fiscal year 2010. Earnings per share are expected to grow at 10% for the next 5 years. There are 8 analyst estimates available for fiscal 2010, of which one has been increased in the past 30 days. The stock has provided a positive surprise of 9.62% for the quarter ended July 2009 while for the quarter-end January 2009, negative surprise was to the extent of 13.64%. On an average, there has been a negative earnings surprise of 2% over the trailing four quarters. All the above factors along with gradually improving macro environment have helped the stock retain its Zacks #3 Rank. This implies a long-term Neutral recommendation on the stock, which means that it will perform in line with the broader U.S. equity market over the next six to twelve months.

Pall Corporation manufactures and markets filtration, purification and separation products and integrated systems solutions worldwide. The company’s Life Sciences segment offers technologies that facilitate the process of drug discovery, development and production used in laboratories, pharmaceutical and biotechnology industries, blood centers and hospitals at the point of patient care. The company’s Industrial segment offers enabling and process enhancing technologies for various industries such as aerospace, transportation, micro and consumer electronics, municipal and industrial water, fuels, chemicals, energy, and food and beverages.

Zacks Investment Research

1. (PLL) Pall Corporation Matches Earnings EstimatesPall Corporation (PLL) reported first quarter 2010 earnings per share of 40 cents, matching the...
2. (INFY) Infosys Technologies Limited’s BPO Subsidiary Acquires McCamish SystemsInfosys BPO Limited, the business processing outsourcing subsidiary of Infosys Technologies Limited (INFY), announced the...
3. (PLL) Pall Corporation – Sees Economic Conditions ImprovingPall Corporation (PLL) saw quarter over quarter sales growth in its fiscal fourth quarter as...
4. (PLL) Pall Corporation Beats EstimatesPall Corporation (PLL) reported fourth quarter 2009 revenues of $652 million and net earnings of $69.5...
5. (PLL) Russian Helicopters Chooses Pall CorporationPall Corp. (PLL) recently agreed with Russian Helicopters JSC to provide Centrisep air cleaner filters...
6. (UTX) United Technologies’ Carrier Corporation Acquires StrionAirCarrier Corp., a division of United Technologies Corp. (UTX), acquired StrionAir, a producer of proprietary...

Search Posts by Tag: Morton's Restaurant Group Inc. | MRT | Pall Corporation | PLL | Diversified Machinery | Industrial Goods

RSS Feeds by Tag: Morton's Restaurant Group Inc. | MRT | Pall Corporation | PLL | Diversified Machinery | Industrial Goods |

Other Posts by: vitalstocks | RSS Feed for this author